We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Pre-Shaped Guidewire Sized for Smaller Ventricles

By HospiMedica International staff writers
Posted on 03 Aug 2015
Print article
The Boston Scientific Safari2 pre-shaped guidewire
The Boston Scientific Safari2 pre-shaped guidewire (Photo courtesy of Boston Scientfic )
An enhanced version of the Safari guidewire facilitates the introduction and placement of interventional devices within the heart.

The Boston Scientific Safari2 pre-shaped guidewire is designed to offer streamlined device delivery with enhanced wire predictability and shape retention for placing interventional devices within the heart, including those used with transcatheter aortic valve implantation or replacement procedures (TAVI/R). The Safari2 product line offers a wide choice with three curve sizes, including a new extra small curve designed for procedures involving patients with smaller ventricles. Prior to the Safari guidewire, physicians used peripheral intervention guidewires manually shaped for TAVI procedures.

The Safari2 Guidewire is designed to complement the Boston Scientific Lotus Valve System, a next-generation TAVI/R device designed to give physicians more control throughout the procedure. The Lotus Valve System offers an alternative treatment for patients with severe aortic stenosis who are at high risk for surgical valve replacement. The Safari and Safari2 guidewires and the Lotus Valve System are products of Boston Scientific (Natick, MA, USA), and have received the European Community CE marking of approval. They are distributed separately.

“The Safari2 Guidewire reflects our dedication and our commitment to meaningful innovation in the treatment of structural heart disorders,” said Tom Fleming, vice president and general manager of the structural heart division at Boston Scientific. “We will continue to invest in technologies like Safari2 which facilitate successful TAVI/R outcomes and improve quality of life for patients with valvular disease worldwide.”

“Having a pre-shaped, universal TAVR guidewire helps physicians deliver the replacement valve with reliability and consistency,” commented Wesley Pederson, MD, director of valve and structural heart disease at the Minneapolis Heart Institute Foundation (MHIF; MN, USA; www.mplsheart.org). “This is a wonderful development to have a smaller curve size so that we can offer this less invasive treatment option to a broader range of patients, because valvular disease can have a devastating impact on patient survival and quality of life.”

TAVI involves the percutaneous insertion of a catheter containing a replacement valve at a site in the groin or the left chest. The new valve is pushed into the correct site where the surgeon expands it and pushes the old one aside. The procedure is much less invasive than traditional open heart aortic valve replacement and does not require putting the patient on a heart and lung machine, so it can be performed on those who cannot have open heart surgery.

Related Links:

Boston Scientific 



Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
12-Lead Electrocardiograph
ASPEL ECG GREY v.07.325
New
Leg Wraps
Leg Wraps
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A mechanosensing-based approach offers a potential path to the treatment for cardiac fibrosis (Photo courtesy of Adobe Stock)

Mechanosensing-Based Approach Offers Promising Strategy to Treat Cardiovascular Fibrosis

Cardiac fibrosis, which involves the stiffening and scarring of heart tissue, is a fundamental feature of nearly every type of heart disease, from acute ischemic injuries to genetic cardiomyopathies.... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more